171 related articles for article (PubMed ID: 38711827)
1. Journey into the Esophageal Complications: Decoding Systemic Sclerosis with Cutting-Edge Endoscopy, Manometry, and Ambulatory pH-Study.
Amin OAH; Mirza RR; Hussein HA; Khudhur ZO; Awla HK; Smail SW
Int J Gen Med; 2024; 17():1823-1831. PubMed ID: 38711827
[TBL] [Abstract][Full Text] [Related]
2. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.
Arif T; Masood Q; Singh J; Hassan I
BMC Gastroenterol; 2015 Feb; 15():24. PubMed ID: 25888470
[TBL] [Abstract][Full Text] [Related]
3. Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis.
Zentilin P; Savarino V; Marabotto E; Murdaca G; Sulli A; Pizzorni C; Puppo F; Savarino E
Semin Arthritis Rheum; 2018 Feb; 47(4):569-574. PubMed ID: 28870413
[TBL] [Abstract][Full Text] [Related]
4. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
5. Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.
Stern EK; Carlson DA; Falmagne S; Hoffmann AD; Carns M; Pandolfino JE; Hinchcliff M; Brenner DM
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 29110377
[TBL] [Abstract][Full Text] [Related]
6. Irritable bowel syndrome and organic diseases: a comparative analysis of esophageal motility.
Thomaidis T; Goetz M; Gregor SP; Hoffman A; Kouroumalis E; Moehler M; Galle PR; Schwarting A; Kiesslich R
World J Gastroenterol; 2013 Oct; 19(38):6408-15. PubMed ID: 24151359
[TBL] [Abstract][Full Text] [Related]
7. High-resolution oesophageal manometry and 24-hour impedance-pH study in systemic sclerosis patients: association with clinical features, symptoms and severity.
Raja J; Ng CT; Sujau I; Chin KF; Sockalingam S
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):115-121. PubMed ID: 26843456
[TBL] [Abstract][Full Text] [Related]
8. Esophageal Involvement and Determinants of Perception of Esophageal Symptoms Among South Koreans With Systemic Sclerosis.
Lee JS; Kim HS; Moon JR; Ryu T; Hong SJ; Cho YS; Park J; Lee TH
J Neurogastroenterol Motil; 2020 Sep; 26(4):477-485. PubMed ID: 32989185
[TBL] [Abstract][Full Text] [Related]
9. The pattern of esophageal manometry in progressive systemic sclerosis.
Al-Amri SM
Saudi Med J; 2003 Jan; 24(1):68-71. PubMed ID: 12590279
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and management of esophageal manifestations in systemic sclerosis.
Denaxas K; Ladas SD; Karamanolis GP
Ann Gastroenterol; 2018; 31(2):165-170. PubMed ID: 29507463
[TBL] [Abstract][Full Text] [Related]
11. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.
Ntoumazios SK; Voulgari PV; Potsis K; Koutis E; Tsifetaki N; Assimakopoulos DA
Semin Arthritis Rheum; 2006 Dec; 36(3):173-81. PubMed ID: 17045629
[TBL] [Abstract][Full Text] [Related]
12. Esophageal manometry, esophagogastroduodenoscopy, and duodenal mucosal histopathology in systemic sclerosis.
Adarsh MB; Sharma SK; Prasad KK; Dhir V; Singh S; Sinha SK
JGH Open; 2019 Jun; 3(3):206-209. PubMed ID: 31276037
[TBL] [Abstract][Full Text] [Related]
13. Role of esophageal function tests in diagnosis of gastroesophageal reflux disease.
Patti MG; Diener U; Tamburini A; Molena D; Way LW
Dig Dis Sci; 2001 Mar; 46(3):597-602. PubMed ID: 11318538
[TBL] [Abstract][Full Text] [Related]
14. Advances in the evaluation and management of esophageal disease of systemic sclerosis.
Carlson DA; Hinchcliff M; Pandolfino JE
Curr Rheumatol Rep; 2015 Jan; 17(1):475. PubMed ID: 25475597
[TBL] [Abstract][Full Text] [Related]
15. Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients.
Yarze JC; Varga J; Stampfl D; Castell DO; Jimenez SA
Am J Gastroenterol; 1993 Jun; 88(6):870-6. PubMed ID: 8503383
[TBL] [Abstract][Full Text] [Related]
16. Interstitial lung disease and gastroesophageal reflux disease: key role of esophageal function tests in the diagnosis and treatment.
Soares RV; Forsythe A; Hogarth K; Sweiss NJ; Noth I; Patti MG
Arq Gastroenterol; 2011; 48(2):91-7. PubMed ID: 21709948
[TBL] [Abstract][Full Text] [Related]
17. Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?
Vardar R; Keskin M
Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S16-S21. PubMed ID: 29199161
[TBL] [Abstract][Full Text] [Related]
18. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
[TBL] [Abstract][Full Text] [Related]
19. Assessment of clinical severity and investigation of uncomplicated gastroesophageal reflux disease and noncardiac angina-like chest pain.
Lemire S
Can J Gastroenterol; 1997 Sep; 11 Suppl B():37B-40B. PubMed ID: 9347176
[TBL] [Abstract][Full Text] [Related]
20. Esophageal manometry in 28 systemic sclerosis Brazilian patients: findings and correlations.
Calderaro DC; de Carvalho MA; Moretzsohn LD
Dis Esophagus; 2009; 22(8):700-4. PubMed ID: 19664079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
